| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $24.1M | — |
| Cost of Revenue | $12.5M | — |
| Gross Profit | $11.5M | — |
| R&D Expense | $6.7M | — |
| SG&A Expense | $11.2M | — |
| Operating Income | -$9.9M | — |
| Interest Expense | $792K | +428.0% |
| Income Tax | $0 | — |
| Net Income | -$10.2M | — |
| EPS (Basic) | -$0.22 | — |
| EPS (Diluted) | -$0.22 | — |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.4M | +251.9% |
| Accounts Receivable | $2.6M | +58.1% |
| Inventory | $6.3M | +184.8% |
| Current Assets | $44.8M | +213.4% |
| Total Assets | $48.6M | +168.1% |
| Current Liabilities | $5.3M | -80.5% |
| Long-term Debt | $12.2M | -66.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.7M | — |
| Capital Expenditures | $595K | — |
| Investing Cash Flow | -$5.1M | — |
| Financing Cash Flow | $49.5M | — |
| Free Cash Flow | -$20.3M | — |
| Total Liabilities |
| $17.3M |
| -60.0% |
| Stockholders' Equity | $31.4M | +225.2% |